Genomics

Dataset Information

0

Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer (NRG1)

ABSTRACT: Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer (NRG1)

PROVIDER: PRJNA1132247 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
Other
SRR29716816_1.fastq.gz Fastqsanger.gz
SRR29716816_2.fastq.gz Fastqsanger.gz
SRR29716822_1.fastq.gz Fastqsanger.gz
SRR29716822_2.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 5

Similar Datasets

Transcriptomics Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer (NRG1)
2025-06-25 | GSE271580 | GEO
Transcriptomics Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer
2025-06-25 | GSE284054 | GEO
Transcriptomics Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer (ASPN)
2025-06-25 | GSE271579 | GEO
Transcriptomics Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer [VCaP_EnzaResistant_9817-HYW]
2025-06-25 | GSE271742 | GEO
Transcriptomics Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer [NRG1_MyCCaP_10722-AH]
2025-06-25 | GSE271740 | GEO
Transcriptomics Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer [LNCaP_EnzaResistant_9445-HYW]
2025-06-25 | GSE271739 | GEO
Transcriptomics Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer [ASPN_MyCCaP_10111-AH]
2025-06-25 | GSE271738 | GEO
Genomics Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer
| PRJNA1196915 | ENA
Genomics Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer (ASPN)
| PRJNA1132245 | ENA
Genomics Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer [LNCaP_EnzaResistant_9445-HYW]
| PRJNA1133010 | ENA